[1. Armstrong DG., Jude EB.: The role of matrix metalloproteinases in wound healing. J Am Pediatr Med Assoc., 92, 12, 2002.]Search in Google Scholar
[2. Bouletreau P.J., Steinbrech D., Spector J.A. et al: Gene expression of transforming growth factor-beta 3 and tissue inhibitor of metalloproteinase type 1 during membranous bone healing in rats. J Craniofac Surg., 11, 521, 2000.]Search in Google Scholar
[3. Brew K., Dinakarpandian D., Nagase H.: Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta, 1477, 267, 2000.10.1016/S0167-4838(99)00279-4]Search in Google Scholar
[4. Cha H., Kopetzki E., Huber R. et al. Structural basis of the adaptive molecular recognition by MMP9. J Mol Biol., 320, 1065, 2002.]Search in Google Scholar
[5. Chubinskaya S., Huch K., Mikecz K. et al.: Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints. Lab Invest., 74, 232, 1996.]Search in Google Scholar
[6. Cuzner M.L., Gveric D., Strand C. et al.: The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution. J Neuropathol Exp Neurol., 55, 1194, 1996.]Search in Google Scholar
[7. Danielsen P.L., Holst A.V., Maltesen H.R. et al.: Matrix metalloproteinase-8 overexpression prevents proper tissue repair. Surgery, 150, 897, 2011.]Search in Google Scholar
[8. Dejonckheere E., Vandenbroucke R.E., Libert C.: Matrix metalloproteinase8 has a central role in inflammatory disorders and cancer progression. Cytokine Growth Factor Rev., 22, 73, 2011.]Search in Google Scholar
[9. Docherty A.J., Lyons A., Smith B.J. et al.: Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroidpotentiating activity. Nature, 318, 66, 1985.]Search in Google Scholar
[10. Duerr S., Stremme S., Soeder S., et al.: MMP-2/gelatinase A is a gene product of human adult articular chondrocytes and is increased in osteoarthritic cartilage. Clin Exp Rheumatol., 22, 603, 2004.]Search in Google Scholar
[11. Fic P., Zakrocka I., Kurzepa J., Stepulak A.: Mat r ix metalloproteinases and atherosclerosis. Postepy Hig Med Dosw (Online), 65, 16, 2011.]Search in Google Scholar
[12. Galazka G., Windsor L.J., Birkedal-Hansen H., Engler JA.: APMA (4-aminophenylmercuric acetate) activation of stromelysin-1 involves protein interactions in addition to those with cysteine-75 in the propeptide. Biochemistry, 35, 11221, 1996.]Search in Google Scholar
[13. Gross J., Lapiere C.M.: Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci USA., 48, 1014, 1962.]Search in Google Scholar
[14. Guedez L., Stetler-Stevenson W.G., Wolff L. et al.: In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J Clin Invest., 102, 2002, 1998.]Search in Google Scholar
[15. Hatibović-Kofman S., Raimundo L., Zheng L. et al.: Fracture resistance and histological findings of immature teeth treated with mineral trioxide aggregate. Dent Traumatol., 24, 272, 2008.]Search in Google Scholar
[16. Isnard N., Legeais J.M., Renard G., Robert L.: Effect of hyaluronan on MMP expression and activation. Cell Biol Int., 25, 735, 2001.]Search in Google Scholar
[17. Kalfas I.H.: Principles of bone healing. Neurosurg Focus, 10, 7, 2001.10.3171/foc.2001.10.4.2]Search in Google Scholar
[18. Kapila S., Xie Y., Wang W.: Induction of MMP-1 (collagenase-1) by relaxin in fibrocartilaginous cells requires both the AP-1 and PEA-3 promoter sites. Orthod Craniofac Res., 12, 178, 2009.]Search in Google Scholar
[19. Knauper V., Cowell S., Smith B. et al.: The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem., 272, 7608, 1997.]Search in Google Scholar
[20. Krane S.M.: Is collagenase (matrix metalloproteinase-1) necessary for bone and other connective tissue remodeling? Clin Orthop Relat Res., 313, 47, 1995.]Search in Google Scholar
[21. Kurzepa J., Bartosik-Psujek H., Suchozebrska-Jesionek D. et al.: Role of matrix metalloproteinases in the pathogenesis of multiple sclerosis. Neurol Neurochir Pol., 39, 63, 2005.]Search in Google Scholar
[22. Lee J.Y., Taub P.J., Wang L. et al.: Identification of CITED2 as a negative regulator of fracture healing. Biochem Biophys Res Commun., 387, 641, 2009.]Search in Google Scholar
[23. Leeman M.F., Curran S., Murray G.I.: The structure, regulation, and function of human matrix metalloproteinase-13. Crit Rev Biochem Mol Biol., 37, 149, 2002.10.1080/10409230290771483]Search in Google Scholar
[24. Lenglet S., Mach F., Montecucco F.: Role of mat r ix metalloproteinase-8 in atherosclerosis. Mediators Inflamm., 2013, 659282, 2013.]Search in Google Scholar
[25. Li H., Ezra D.G., Burton M.J., Bailly M.: Doxycycline prevents matrix remodeling and contraction by trichiasis-derived conjunctival fibroblasts. Invest Ophthalmol Vis Sci., 54, 4675, 2013.]Search in Google Scholar
[26. Li N.G., Shi Z.H., Tang Y.P. et al.: New hope for the treatment of osteoarthritis through selective inhibition of MMP-13. Curr Med Chem., 18, 977, 2011.]Search in Google Scholar
[27. Loy M., Burggraf D., Martens K.H. et al.: A gelatin in situ-overlay technique localizes brain matrix metalloproteinase activity in experimental focal cerebral ischemia. J Neurosci Methods, 116, 125, 2002.]Search in Google Scholar
[28. Madro A., Kurzepa J., Czechowska G. et al. Gelatinase activities and TIMP-2 serum level in alcohol cirrhosis and chronic pancreatitis. Curr Iss Pharm Med Sci., 26, 57, 2013.]Search in Google Scholar
[29. Madsen D.H., Jurgensen H.J., Ingvarsen S. et al.: Differential Actions of the Endocytic Collagen Receptor uPARAP/Endo180 and the Collagenase MMP-2 in Bone Homeostasis. PLoS One, 8, e71261, 2013.10.1371/journal.pone.0071261]Search in Google Scholar
[30. McCawley L.J., Matrisian L.M.: Matrix metalloproteinases: they’re not just for matrix anymore! Curr Opin Cell Biol., 13, 534, 2001.]Search in Google Scholar
[31. Mott J.D., Werb Z.: Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol., 16, 558, 2004.]Search in Google Scholar
[32. Murphy G., Knauper V.: Relating matrix metalloproteinase structure to function: why the “hemopexin” domain? Matrix Biol., 15, 511, 1997.]Search in Google Scholar
[33. Nagase H., Visse R., Murphy G.: Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res., 69, 562, 2006.]Search in Google Scholar
[34. Nomura S., Yoshimura K., Akiyama N. et al: HMG-CoA reductase inhibitors reduce matrix metalloproteinase-9 activity in human varicose veins. Eur Surg Res., 37, 370, 2005.]Search in Google Scholar
[35. Opdenakker G., Van den Steen P.E., Van Damme J.: Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol., 22, 571, 2001.]Search in Google Scholar
[36. Palosaari H., Wahlgren J., Larmas M. et al.: The expression of MMP-8 in human odontoblasts and dental pulp cells is down-regulatedby TGF-beta1. J Dent Res., 79, 77, 2000.]Search in Google Scholar
[37. Pardo A., Selman M.: MMP-1: the elder of the family. Int J Biochem Cell Biol., 37, 283, 2005.10.1016/j.biocel.2004.06.017]Search in Google Scholar
[38. Peppin G.J., Weiss S.J.: Act ivat ion of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils. Proc Natl Acad Sci USA., 83, 4322, 1986.10.1073/pnas.83.12.4322]Search in Google Scholar
[39. Polette M., Nawrocki-Raby B., Gilles C. et al. Tumour invasion and matrix metalloproteinases. Crit Rev Oncol Hematol., 49, 179, 2004.10.1016/j.critrevonc.2003.10.008]Search in Google Scholar
[40. Rowsell S., Hawtin P., Minshull C.A. et al.: Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor. J Mol Biol., 319, 173, 200210.1016/S0022-2836(02)00262-0]Search in Google Scholar
[41. Sang Q.X., Birkedal-Hansen H., Van Wart H.E.: Proteolytic and non-proteolytic activation of human neutrophil progelatinase B. Biochim Biophys Acta, 1251, 99, 1995.]Search in Google Scholar
[42. Sato H., Takino T., Okada Y. et al. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature, 370, 61, 1994.]Search in Google Scholar
[43. Schmidt R., Bultmann A., Ungerer M. et al.: Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction. Circulation, 113, 834, 2006.]Search in Google Scholar
[44. Seltzer J.L., Lee A.Y., Akers K.T. et al.: Activation of 72-kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction. Exp Cell Res., 213, 365, 1994.]Search in Google Scholar
[45. Serra P., Bruczko M., Zapico J.M. et al.: MMP-2 selectivity in hydroxamate-type inhibitors. Curr Med Chem., 19, 1036, 2012.]Search in Google Scholar
[46. Smigielski J., Kołomecki K., Ziemniak P. et al.: Degradation of collagen by metalloproteinase 2 in patients with abdominal hernias. Eur Surg Res., 42, 118, 2009.]Search in Google Scholar
[47. Stetler-Stevenson W.G., Bersch N., Golde D.W.: Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity. FEBS Lett., 296, 231, 1992.]Search in Google Scholar
[48. Stickens D., Behonick D.J., Ortega N. et al.: Altered endochondral bone development in matrix metalloproteinase-13 deficient mice. Development, 131, 5883, 2004.]Search in Google Scholar
[49. Uchida M., Shima M., Chikazu D. et al.: Transcriptional induction of matrix metalloproteinase-13 (collagenase-3) by 1α,25- dihydroxyvitamin D3 in mouse osteoblastic MC3T3-E1 cells. J Bone Min Res., 16, 221, 2001.]Search in Google Scholar
[50. Van Lint P., Libert C.: Matrix metalloproteinase-8: cleavage can be decisive. Cytokine Growth Factor Rev., 17, 217, 2006.]Search in Google Scholar
[51. Vu T.H., Shipley J.M., Bergers G. et al.: MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell, 93, 411, 1998.]Search in Google Scholar
[52. Wang X., Yu Y.Y., Lieu S. et al.: MMP9 regulates the cellular response to inflammation after skeletal injury. Bone, 52,111, 2013.]Search in Google Scholar
[53. Weiss S., Zimmermann G., Pufe T. et al.: The systemic angiogenic response during bone healing. Arch Orthop Trauma Surg., 127, 989, 2009.]Search in Google Scholar
[54. White L.A., Mitchell T.I., Brinckerhoff CE.: Transforming growth factor beta inhibitory element in the rabbit matrix metalloproteinase-1 (collagenase-1) gene functions as a repressor of constitutive transcription. Biochim Biophys Acta, 1490, 259, 2000.]Search in Google Scholar
[55. Whitelock J.M., Murdoch A.D., Iozzo R.V., Underwood P.A.: The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J Biol Chem., 271, 10079, 1996.10.1074/jbc.271.17.100798626565]Search in Google Scholar
[56. Wilhelm S.M., Collier I.E., Marmer B.L. et al.: SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem., 264, 17213, 1989.]Search in Google Scholar
[57. Witty J.P., Foster S.A., Stricklin G.P. et al.: Parathyroid hormoneinduced resorption in fetal rat limb bones is associated with production of the metalloproteinases collagenase and gelatinase B. J Bone Min Res., 11, 72, 1996.]Search in Google Scholar
[58. Yu Y., Koike T., Kitajima S. et al.: Temporal and quantitative analysis of expression of metalloproteinases (MMPs) and their endogenous inhibitors in atherosclerotic lesions. Histol Histopathol., 23, 1503, 2008. ]Search in Google Scholar